The prognostic value of tumour stroma ratio and tumour budding in stage II colon cancer. A nationwide population-based study

被引：0
|
作者：
Ann Christina Eriksen
Flemming B. Sørensen
Jan Lindebjerg
Henrik Hager
René dePont Christensen
Sanne Kjær-Frifeldt
Torben F. Hansen
机构：
[1] Vejle Hospital,Danish Colorectal Cancer Center South
[2] University of Southern Denmark,Institute of Regional Health Research
[3] Lillebaelt Hospital,Department of Pathology
[4] University Institute of Pathology,Department of Clinical Medicine
[5] Aarhus University Hospital,Research Unit of General Practice
[6] University of Aarhus,undefined
[7] Danish Colorectal Cancer Group (DCCG),undefined
[8] University of Southern Denmark,undefined
来源：
International Journal of Colorectal Disease | 2018年 / 33卷
关键词：
Colon cancer stage II; Prognostic markers; Survival; Tumour budding; Tumour stroma ratio;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1115 / 1124
页数：9
相关论文
共 50 条
  • [41] Prognostic value of stem cell quantification in stage II colon cancer.
    Angeles Vaz, M.
    Carlos Martinez, Juan
    Devesa, Manuel
    Die Trill, Javier
    Abraira, Victor
    Riquelme, Alejandro
    Carrato, Alfredo
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [42] Tumour budding as a potential prognostic factor in adenocarcinoma of the colon - a pilot study
    Brask, J.
    Kristensen, B.
    Sasor, A.
    APMIS, 2010, 118 : 10 - 10
  • [43] Tumor Stroma Ratio and Tumour Budding as Independent Predictors for Survival in Colorectal Cancer Patients
    AboElnasr, Lamia
    El-Rebey, Hala
    Mohamed, Asmaa El Dein
    Abdou, Asmaa
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 608 - 608
  • [44] Tumor Stroma Ratio and Tumour Budding as Independent Predictors for Survival in Colorectal Cancer Patients
    AboElnasr, Lamia
    El-Rebey, Hala
    Mohamed, Asmaa El Dein
    Abdou, Asmaa
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 608 - 608
  • [45] Prognostic and predictive values of tumour budding in stage IV colorectal cancer
    Nagata, K.
    Shinto, E.
    Yamadera, M.
    Shiraishi, T.
    Kajiwara, Y.
    Okamoto, K.
    Mochizuki, S.
    Hase, K.
    Kishi, Y.
    Ueno, H.
    BJS OPEN, 2020, 4 (04): : 693 - 703
  • [46] Prognostic value of tumour budding in oesophageal cancer: a meta-analysis
    Almangush, Alhadi
    Karhunen, Markku
    Hautaniemi, Sampsa
    Salo, Tuula
    Leivo, Ilmo
    HISTOPATHOLOGY, 2016, 68 (02) : 173 - 182
  • [47] The other colon cancer: a population-based cohort study of appendix tumour trends and prognosis
    Kathrin, Halfter
    Gabriele, Schubert-Fritschle
    Frederick, Klauschen
    Jens, Werner
    Mayerle, Julia
    Weichert, Wilko
    Friess, Helmut
    Schmid, Roland
    Kremer, Marcus
    Ruppert, Reinhard
    Hoelzl, Jurgen
    Krenz, Detlef
    Nerlich, Andreas
    Agha, Ayman
    Fuchs, Martin
    Becker, Ingrid
    Nowak, Kai
    Engel, Jutta
    Schlesinger-Raab, Anne
    COLORECTAL DISEASE, 2023, 25 (05) : 943 - 953
  • [48] Tumour budding: a strong and reproductible prognostic marker in stage II colorectal carcinoma
    Baccouche, A.
    Abdessayed, N.
    Majdoub, W.
    Zahmoul, T.
    Hamchi, H.
    Belkacem, O.
    Mokni, M.
    Hmissa, S.
    VIRCHOWS ARCHIV, 2022, 481 (SUPPL 1) : S231 - S231
  • [49] Tumour budding is a strong and independent prognostic factor in pancreatic cancer. Reply to Comment
    Karamitopoulou, Eva
    Gloor, B.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (10) : 2458 - 2459
  • [50] The prognostic value of tumor budding in a thoroughly characterized stage II colon cancer population in the context of a national screening program
    Kristensen, Maria Pihlmann
    Korsgaard, Ulrik
    Timm, Signe
    Hansen, Torben Frostrup
    Zlobec, Inti
    Hager, Henrik
    Kjaer-Frifeldt, Sanne
    HUMAN PATHOLOGY, 2024, 146 : 15 - 22
12345